555 related articles for article (PubMed ID: 12922099)
1. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
Chen W; Shen H; Webb A; KuoLee R; Conlan JW
Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
[TBL] [Abstract][Full Text] [Related]
2. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
[TBL] [Abstract][Full Text] [Related]
3. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
5. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
6. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
[TBL] [Abstract][Full Text] [Related]
7. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.
Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
PLoS One; 2010 Oct; 5(10):e13349. PubMed ID: 20967278
[TBL] [Abstract][Full Text] [Related]
8. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
De Pascalis R; Chou AY; Ryden P; Kennett NJ; Sjöstedt A; Elkins KL
mBio; 2014 Apr; 5(2):e00936. PubMed ID: 24713322
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
Shen H; Chen W; Conlan JW
Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
[TBL] [Abstract][Full Text] [Related]
10. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
Shen H; Chen W; Conlan JW
Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
[TBL] [Abstract][Full Text] [Related]
11. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
[TBL] [Abstract][Full Text] [Related]
13. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
14. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen.
Conlan JW; Shen H; Webb A; Perry MB
Vaccine; 2002 Oct; 20(29-30):3465-71. PubMed ID: 12297391
[TBL] [Abstract][Full Text] [Related]
15. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
[TBL] [Abstract][Full Text] [Related]
16. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
Mahawar M; Rabadi SM; Banik S; Catlett SV; Metzger DW; Malik M; Bakshi CS
PLoS One; 2013; 8(4):e61539. PubMed ID: 23613871
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis.
Chen W; KuoLee R; Shen H; Conlan JW
Microb Pathog; 2004 Jun; 36(6):311-8. PubMed ID: 15120157
[TBL] [Abstract][Full Text] [Related]
18. Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen.
Conlan JW; Vinogradov E; Monteiro MA; Perry MB
Microb Pathog; 2003 Jan; 34(1):39-45. PubMed ID: 12620383
[TBL] [Abstract][Full Text] [Related]
19. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
Jia Q; Horwitz MA
Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
[No Abstract] [Full Text] [Related]
20. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
